E2F2 protein identified as potential therapeutic target to prevent metabolic fatty liver disease progression
An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent metabolic…
Japan’s registry transforms outcomes for infants with biliary atresia
Biliary atresia (BA) is the leading cause of liver failure in infants, marked by progressive destruction of the…
Gut probiotic Christensenella tenuis reduces endotoxemia and improves metabolism in obese mice
This study is reported by the team of Professor Shuang-jiang Liu from Shandong University. The study reveals that…